"INAMDAR MULTISPECIALITY HOSPITAL – PUNE is an endeavour to alleviate the suffering of patients, by providing the best of healthcare at an optimal cost. A Multispeciality hospital that is centrally located and adorned with state-of –the-art infrastructure and an eminent panel of doctors are in a nutshell what we are all about. A highly sophisticated setup and a panel of super specialists functioning smoothly in a culture of care, commitment, dedication and concern. Commitment To excellence and giving the patients and attendants, homely and secured facilities ensuring a speedy recovery. We understand the importance of your time."

During the past decade, CIMET's Inamdar Multispeciality Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CIMET's Inamdar Multispeciality Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Abbott" with 1 trials sponsored, "Adocia" with 1 trials sponsored, "Allergan" with 1 trials sponsored and "Ausio Pharmaceuticals, LLC" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CIMET's Inamdar Multispeciality Hospital" #1 collaborator was "Datamap" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Virchow Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "CIMET's Inamdar Multispeciality Hospital" are "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Benign Prostatic Hyperplasia" (1 trials), "Diabetes Mellitus" (1 trials), "Diabetic Foot Ulcer" (1 trials) and "Female Infertility" (1 trials). Many other conditions were trialed in "CIMET's Inamdar Multispeciality Hospital" in a lesser frequency.

Most popular intervention types in "CIMET's Inamdar Multispeciality Hospital" are "Drug" (6 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Amivantamab Intravenous" (1 trials), "Amivantamab Subcutaneous and Co-Formulated with Recombinant Human Hyaluronidase (SC CF)" (1 trials), "BioChaperone PDGF-BB" (1 trials) and "Dydrogesterone 30 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "CIMET's Inamdar Multispeciality Hospital" are 6 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CIMET's Inamdar Multispeciality Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in CIMET's Inamdar Multispeciality Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CIMET's Inamdar Multispeciality Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".